| abstract |
Disclosed are polymer conjugates of camptothecin derivatives with increased circulation half-life. In a preferred embodiment, the lactone of the E ring of the camptothecin derivative is opened, and a polymer such as PEG can be attached to its 17- or 20-position. A representative example of such a compound is (I), and its preparation and use are also disclosed. [Chemical 1] |